+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Surgical Blades Market - Forecasts from 2022 to 2027

  • PDF Icon


  • 138 Pages
  • October 2022
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 5682013
The global surgical blades market is estimated to grow at a CAGR of 4.70%, from a market size of US$105.955 million in 2020 to a market size of US$146.134 million by 2027.

The surgical blade market is projected to grow in the forecast period with the growing number of surgical procedures globally, escalating cosmetic surgeries, and rising health expenditures. The increasing number of Centers of Excellence (CoE) worldwide for disease management is fueling market growth in the forecast period.

The ageing population of the world requires improved and focused healthcare activities for the treatment of their chronic diseases as a result of their old age. This will further provide an opportunity for the market to grow in the forecast period for specific treatment surgeries. However, stringent government regulations will hamper market growth moderately in the forecast period.

Furthermore, the presence of cardiovascular diseases worldwide will impact the market's growth positively with the growing number of cardiovascular problems worldwide. Geographically. North America and Europe are projected to hold a significant market share, followed by the Asia Pacific region's growth at a high CAGR during the forecast period.

Furthermore, the prevalence of organ donation and transplantation activities worldwide further strengthens the growth prospects of global surgical blades in the forecast period, bolstering the market demand over the next five years. Additionally, the growing adoption of minimally invasive surgeries worldwide provides an opportunity for the market to flourish in the forecast period.

The increasing number of surgical procedures worldwide is projected to fuel market growth in the forecast period.

The growing number of surgeries worldwide propels the market growth in the forecast period. For example, in the United Kingdom, the market is poised to grow in the forecast period as surgeries here are considered to be the most critical treatment offered by the National Health Service in secondary care within the country. This is further supported by the growing number of surgeons, especially with the rise in the number of women surgeons, hence, contributing to a surge in the market growth in the forecast period.

Additionally, with the growing number of geriatric people aged 65 years and above in the United Kingdom, the number of age-associated diseases, such as cardiovascular diseases, will increase. Hence the market for surgical blades will also continue to soar over the next five years. According to the World Bank estimates, the geriatric population (65 years of age or older) in the United Kingdom has grown from 11.706 million in 2015 to 12.231 million in 2018.

Moreover, the rising health expenditure of the country is further providing an opportunity for the market to grow in the forecast period. According to the Office for National Statistics-UK Health Accounts, health expenditure in the United Kingdom increased from 171.6 £billion in 2016 to 177.4 £billion in 2017.

According to the European Union Statistics, the selected high-growth surgical procedures in Spain include cochlear implantation, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic repair of inguinal hernia, and laparoscopic hysterectomy.

Considering organ donation and transplantation activities, the surgical blades market will continue to grow in the forecast period. Spain is considered the number one country in the world for the highest rate of organ donation, with an organ donation rate of 39.7 in one million inhabitants (source: National Health System of Spain 2016 Annual Report). It has been observed that the trend of organ donation has continued to grow upwards in recent years.

Also, this has given rise to the growing number of transplantations, further fueling the market growth in the forecast period. The kidney transplantation procedure is the most frequently followed by liver transplants. As per the Spain National Health System 2016 annual report estimates, the number of kidney transplant procedures accounted for 2,905 transplants, while the number of liver transplant procedures accounted for 1,162 transplants.

The high prevalence of cardiovascular diseases is fueling the market demand in the forecast period.

Cardiovascular Diseases (CVDs) are the leading global cause of death. The prevalence of high blood pressure, obesity, and diabetes in a population contribute to CVDs. 17.7 million people die annually due to the increasing number of cardiovascular diseases (CVDs). It is responsible for 31% of global deaths (source: World Health Organization). The increasing prevalence worldwide is due to excessive tobacco use, unhealthy diet, physical inactivity, and excessive use of alcohol, giving rise to harmful conditions like high blood pressure, obesity, and high blood glucose levels.

The United States is the global leader in the maximum number of cardiovascular diseases. Worldwide there are more than a billion adults who are overweight, and around 300 million people are under the category of being clinically obese. These are highly prevalent and countries like North America and Western Europe. They die from obesity-related disorders every year; this includes cardiovascular diseases.

Low-income and middle-income countries also face the problem of chronic diseases, including cardiovascular diseases, due to their lack of awareness of disease management and maintaining proper dietary consumption to prevent the occurrence of this disease. In developing countries like India, owing to the changing lifestyle and behavioural patterns, the risk of cardiovascular diseases has started occurring in people who are below 65 years of age. In response, certain government initiatives to detect and treat cardiovascular diseases affect a larger population base and also fuel market growth in the forecast period. Hence, high cardiac/ cardiovascular disease prevalence has a high impact on the growth of the global surgical blade market.

Key Developments

May 2022: Surgical Holdings, a major surgical instrument manufacturer, announced the introduction of a new, green project in support of their sustainability theme. This initiative will help both the business and the National Health Service lower their carbon footprints while also assisting the industry's efforts to achieve net-zero emissions by the year 2050.

October 2020.

With the goal of enhancing patient recuperation, Entrepix Medical unveiled a new surgical blade technology named Planatome. The technology offers surgical tools a very smooth, accurate, and consistent cutting surface by using a unique nano-polishing technique to remove manufacturing flaws seen on conventional scalpels. This significantly reduces harm to human tissue during surgery and enhances the healing process, lowers the risk of infection, and strengthens the incision. It also reduces scarring, pain, and nerve damage.

February 2020: With the aid of an over-moulded surgical blade, Axcesor assisted a client in the introduction of a new product. Overmolding is far more economically possible for applications with lower or moderate volume, although it might be difficult to eliminate flash at the blade. However, Axcesor has successfully achieved zero flashes at the blade, by utilizing? unique plastic insert in the hollow or core of the blade that creates an interference fit at the blade shutdown.

Impact of the COVID-19 pandemic

The COVID-19 outbreak led to a global economic slowdown, leading to a decrease in revenue in major sectors, due to the implementation of strict lockdown and social distancing regulations. Government initiatives also led to the suspension of non-essential surgeries during the outbreak, leading to a decrease in demand for surgical blades. According to the World Economic Forum, during the 12 weeks of the COVID-19 pandemic's peak interruption, 28 million elective procedures may have been postponed or cancelled throughout the world. 38% of cancer surgeries worldwide were rescheduled or cancelled. This led to a decrease in demand for the market during the pandemic. However, the market soon saw an increase in demand with the resumption of healthcare procedures. Additionally, as most countries have started to lift their COVID-19 regulations, the market is expected to increase significantly in the forecasted period.


By Type

  • Sterile
  • Non-Sterile

By Material Type

  • Hardened & Tempered Steel
  • Stainless Steel
  • Carbon Steel

By End-User

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Life Sciences & Biomedical Research Organisation

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Middle East and Africa
  • UAE
  • Israel
  • Saudi Arabia
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
Frequently Asked Questions about the Surgical Blades Market

What is the estimated value of the Surgical Blades Market?

The Surgical Blades Market was estimated to be valued at $105.96 million in 2020.

What is the growth rate of the Surgical Blades Market?

The growth rate of the Surgical Blades Market is 4.7%, with an estimated value of $146.13 million by 2027.

What is the forecasted size of the Surgical Blades Market?

The Surgical Blades Market is estimated to be worth $146.13 million by 2027.

Who are the key companies in the Surgical Blades Market?

Key companies in the Surgical Blades Market include GPC Medical Ltd, Medical Device Business Services, Inc., B. Braun Melsungen AG, Stryker, Smith, Nephew, CONMED, Zimmer Biomet, Swann and Morton Limited.

Table of Contents

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porter’s Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. Surgical Blades Market Analysis, by Type
5.1. Introduction
5.2. Sterile
5.3. Non-Sterile
6. Surgical Blades Market Analysis, by Material Type
6.1. Introduction
6.2. Hardened & Tempered Steel
6.3. Stainless Steel
6.4. Carbon Steel
7. Surgical Blades Market Analysis, by End-User
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Ambulatory Surgery Centers
7.5. Life Sciences & Biomedical Research Organisation
8. Surgical Blades Market Analysis, by Geography
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. UK
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Others
8.5. Middle East and Africa
8.5.1. United Arab Emirates
8.5.2. Israel
8.5.3. Saudi Arabia
8.5.4. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. GPC Medical Ltd
10.2. Medical Device Business Services, Inc.
10.3. B. Braun Melsungen AG
10.4. Stryker
10.5. Smith-Nephew
10.6. CONMED
10.7. Zimmer Biomet
10.8. Swann-Morton Limited

Companies Mentioned

  • GPC Medical Ltd
  • Medical Device Business Services, Inc.
  • B. Braun Melsungen AG
  • Stryker
  • Smith-Nephew
  • Zimmer Biomet
  • Swann-Morton Limited